Profile data is unavailable for this security.
About the company
Nightingale Health Oyj is a Finland-based health technology company whose mission is to build sustainable healthcare and reduce health inequalities. It has developed an advanced health check that provides risk detection for multiple chronic diseases from a single blood sample. The blood analysis technology developed by Nightingale measures a broad group of biomarkers from a single blood sample, recognizing individual disease risks. The Company provides people with comprehensive insights on health, helps them make better decisions regarding their health and connects them with healthcare experts that offer preventative services for maintaining health. Nightingale Health Oy is the Parent Company in the Nightingale Group. The Company has subsidiaries in the United Kingdom, Japan, Sweden, Germany, Singapore, Estonia and the United States.
- Revenue in EUR (TTM)4.69m
- Net income in EUR-18.46m
- Incorporated2002
- Employees100.00
- LocationNightingale Health OyjMannerheimintie 164aHELSINKI 00300FinlandFIN
- Phone+358 207301810
- Websitehttps://nightingalehealth.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncopeptides AB | 5.92m | -25.34m | 69.22m | 75.00 | -- | 111.77 | -- | 11.69 | -1.20 | -1.20 | 0.2798 | 0.0253 | 0.2359 | 0.2049 | 1.79 | 782,225.00 | -100.98 | -148.24 | -125.09 | -215.27 | 97.88 | -- | -428.01 | -2,013.60 | 3.27 | -12.10 | 0.9507 | -- | -10.14 | -- | -14.25 | -- | -7.14 | -- |
| Curasight A/S | -5.98m | -6.46m | 93.62m | 4.00 | -- | 40.04 | -- | -- | -1.13 | -1.13 | -1.07 | 0.3809 | -1.52 | -- | -- | -11,171,250.00 | -163.63 | -37.34 | -313.58 | -40.89 | -- | -- | -- | -- | -- | -16.54 | 0.00 | -- | -27.21 | -- | -40.76 | -- | -- | -- |
| XSpray Pharma AB (publ) | 0.00 | -20.47m | 95.16m | 26.00 | -- | 1.57 | -- | -- | -5.96 | -5.96 | 0.00 | 15.37 | 0.00 | -- | -- | 0.00 | -29.09 | -23.48 | -30.93 | -25.08 | -- | -- | -- | -- | 5.93 | -18.44 | 0.1883 | -- | -- | -- | -58.92 | -- | -14.46 | -- |
| Nykode Therapeutics ASA | 5.68m | -9.23m | 104.20m | 62.00 | -- | 1.25 | -- | 18.33 | -0.3102 | -0.3102 | 0.1945 | 2.89 | 0.0494 | -- | 1.91 | 463,170.70 | -8.03 | 2.32 | -8.66 | 2.60 | -- | -- | -162.46 | 8.51 | -- | -- | 0.0284 | -- | -32.73 | -- | -10.43 | -- | -1.35 | -- |
| Cantargia AB | 29.20m | 13.24m | 121.58m | 23.00 | 10.20 | 4.32 | 8.96 | 4.16 | 0.5068 | 0.5068 | 1.33 | 1.20 | 1.41 | -- | 164.02 | 14,031,360.00 | 63.91 | -56.56 | 80.65 | -63.93 | -- | -- | 45.33 | -- | -- | 76.55 | 0.00 | -- | -- | -- | 42.27 | -- | -- | -- |
| Nightingale Health Oyj | 4.69m | -18.46m | 138.04m | 100.00 | -- | 1.58 | -- | 29.41 | -0.3052 | -0.3052 | 0.0778 | 1.10 | 0.0568 | 0.9444 | 2.79 | 46,930.00 | -22.33 | -15.66 | -24.26 | -16.95 | 75.39 | 75.21 | -393.39 | -447.17 | 8.52 | -- | 0.0511 | -- | 7.69 | 21.38 | -5.71 | -- | -12.69 | -- |
| Solar Foods Oyj | 19.11k | -10.66m | 139.56m | 57.00 | -- | 6.56 | -- | 7,302.83 | -0.433 | -0.433 | 0.0008 | 0.7115 | 0.0004 | -- | 0.0037 | 455.00 | -22.45 | -- | -27.05 | -- | 25,931.57 | -- | -55,808.37 | -- | -- | -7.03 | 0.5092 | -- | 275.15 | -- | -22.57 | -- | -- | -- |
| Intellego Technologies AB | 72.91m | 27.87m | 146.88m | 65.00 | 4.75 | 2.33 | 4.81 | 2.01 | 9.81 | 9.81 | 25.91 | 20.01 | 1.28 | 10.59 | 2.32 | 12,432,400.00 | 49.11 | 17.13 | 61.64 | 23.87 | 70.97 | 58.82 | 38.23 | 21.32 | 4.11 | 5.35 | 0.0617 | -- | 42.25 | 222.71 | 14.78 | -- | -- | -- |
| Thor Medical ASA | 8.83k | -5.20m | 159.74m | 13.00 | -- | 3.77 | -- | 18,093.33 | -0.223 | -0.223 | 0.0004 | 1.36 | 0.0002 | -- | 0.0078 | 11,111.11 | -13.37 | -59.74 | -13.90 | -81.16 | -- | -- | -58,908.00 | -- | 8.78 | -- | 0.018 | -- | -- | -- | -659.00 | -- | -33.37 | -- |
| BioInvent International AB | 23.16m | -30.64m | 167.44m | 124.00 | -- | 2.59 | -- | 7.23 | -4.91 | -4.91 | 3.72 | 10.38 | 0.2614 | -- | 4.90 | 2,147,790.00 | -34.58 | -19.38 | -38.20 | -20.57 | -- | -- | -132.30 | -189.97 | 7.31 | -- | 0.0154 | -- | -37.47 | -13.77 | -29.99 | -- | 21.19 | -- |
| Devyser Diagnostics AB | 22.97m | -2.38m | 168.56m | 115.00 | -- | 5.23 | 1,272.82 | 7.34 | -1.52 | -1.52 | 14.66 | 20.48 | 0.5262 | 1.40 | 5.53 | 1,839,394.00 | -5.64 | -10.61 | -6.60 | -12.04 | 81.96 | 80.33 | -10.71 | -28.67 | 2.27 | -2.03 | 0.1312 | -- | 28.12 | 27.53 | -14.74 | -- | 52.54 | -- |
| Cereno Scientific AB | 0.00 | -10.72m | 193.21m | 5.00 | -- | 9.98 | -- | -- | -0.3987 | -0.3987 | 0.00 | 0.6572 | 0.00 | -- | -- | -- | -30.72 | -20.10 | -32.58 | -21.72 | -- | -- | -- | -- | -- | -1.94 | 0.4817 | -- | -- | -- | -106.89 | -- | 47.93 | -- |
| Egetis Therapeutics AB (publ) | 5.24m | -31.54m | 193.25m | 40.00 | -- | 6.69 | -- | 36.88 | -0.9376 | -0.9376 | 0.1554 | 0.7725 | 0.0945 | 45.53 | 1.93 | 1,582,857.00 | -56.85 | -36.53 | -87.92 | -41.52 | 30.14 | 81.16 | -601.62 | -558.74 | 0.7971 | -45.06 | 0.249 | -- | -19.97 | -11.00 | -5.11 | -- | -- | -- |
Data as of Feb 11 2026. Currency figures normalised to Nightingale Health Oyj's reporting currency: Euro EUR
5.18%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nordea Investment Management AB (Finland)as of 31 Dec 2025 | 1.59m | 3.93% |
| Sp-Fund Management Co. Ltd.as of 30 Jan 2026 | 475.74k | 1.17% |
| Consensus Asset Management AB (Investment Management)as of 30 Dec 2025 | 30.00k | 0.07% |
| Fj�rde AP-fondenas of 30 Jun 2025 | 0.00 | 0.00% |
| Kieger AGas of 31 Mar 2025 | 0.00 | 0.00% |
More ▼
Data from 31 Mar 2025 - 30 Jan 2026Source: FactSet Research Systems Inc.
